BIO
Bio-Rad Laboratories, Inc.
NYSE · Healthcare · Medical - Devices · US
$386.11
−0.46%Forward multiples
Based on analyst estimates
- P/E forward
- 37.48x
- P/E 2026E
- 40.04x
- P/E 2027E
- 37.31x
- P/E 2028E
- 34.37x
- P/S forward
- 3.94x
Trailing multiples
Trailing twelve months
- P/E TTM
- 46.35x
- PEG TTM
- 1.96x
- Price / book
- 1.44x
- Price / sales
- 3.99x
- Price / cash flow
- 20.96x
Enterprise value
- Enterprise value
- $9.9B
- EV / sales
- 3.83x
- EV / EBITDA
- 18.54x
- EV / EBIT
- 42.17x
- Market cap
- $10.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026